SCHEMBL377573

SCHEMBL377573

CCC(N)C(=O)OCc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.56
KMT2A Q03164 2/20 0.50
MAPK1 P28482 2/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
SLC6A2 P23975 1/20 0.50
SLC6A3 Q01959 1/20 0.50
IDO1 P14902 1/20 0.50
CA12 O43570 1/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
CA9 Q16790 1/20 0.49
SLC15A1 P46059 2/20 0.48
LTA4H P09960 1/20 0.48
LAP3 P28838 1/20 0.48
SLC1A1 P43005 4/20 0.47
SLC1A3 P43003 3/20 0.47
SLC1A2 P43004 2/20 0.47
MEN1 O00255 1/20 0.47
CYP1A2 P05177 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2130586 1.00 ALDH1A1 (0.56) ALDH1A1KMT2AMAPK1L3MBTL1TDP1
SCHEMBL2136782 1.00 ALDH1A1 (0.56) ALDH1A1KMT2AMAPK1L3MBTL1TDP1
Trifluoroacetic Acid SCHEMBL27521546 0.91 ALDH1A1 (0.47) ALDH1A1KMT2AMAPK1L3MBTL1TDP1
SCHEMBL5108541 0.87 ALDH1A1 (0.50) ALDH1A1KMT2AMAPK1L3MBTL1TDP1
SCHEMBL27794910 0.87 ALDH1A1 (0.50) ALDH1A1KMT2AMAPK1L3MBTL1TDP1
SCHEMBL3096935 0.86 ALDH1A1 (0.53) ALDH1A1KMT2AMAPK1L3MBTL1TDP1
SCHEMBL12869905 0.86 ALDH1A1 (0.53) ALDH1A1KMT2AMAPK1L3MBTL1TDP1
SCHEMBL21702876 0.86 ALDH1A1 (0.49) ALDH1A1KMT2AMAPK1L3MBTL1TDP1
Hydrochloric Acid SCHEMBL9437522 0.85 ALDH1A1 (0.51) ALDH1A1KMT2AMAPK1L3MBTL1TDP1
SCHEMBL29624272 0.85 ALDH1A1 (0.51) ALDH1A1KMT2AMAPK1L3MBTL1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103284974-B Benzene ring nonyl ester double-layer osmotic pump controlled-release tablet and preparation method thereof WUHAN GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND, PLA (CN) 2016-01-20 CN claimed
CN-103284974-A Phencynonate hydrochloride double-layer osmotic pump controlled release tablet and preparation method thereof WUHAN GENERAL HOSPITAL OF GUANGZHOU MILITARY 2013-09-11 CN claimed
CN-102552205-A Potassium citrate controlled-release tablet preparation and preparation method thereof SHANGHAI INST MATERIA MEDICA 2012-07-11 CN claimed
CN-117736265-B Hypsizygus marmoreus sweet peptide and extraction method and application thereof 陕西科技大学 2025-03-14 CN disclosed
CN-117736265-A Hypsizygus marmoreus sweet peptide and extraction method and application thereof 陕西科技大学 2024-03-22 CN disclosed
US-20230213861-A1 METHOD FOR PRODUCING ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, PATTERN FORMING METHOD, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE FUJIFILM CORPORATION (JP) 2023-07-06 US disclosed
EP-2022852-B1 METHOD FOR PRODUCTION OF OPTICALLY ACTIVE AMINE COMPOUND, RECOMBINANT VECTOR, AND TRANSFORMANT CARRYING THE VECTOR KANEKA CORP (JP) 2017-07-05 EP disclosed
CN-103284974-B Benzene ring nonyl ester double-layer osmotic pump controlled-release tablet and preparation method thereof WUHAN GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND, PLA (CN) 2016-01-20 CN disclosed
CN-102552205-B A kind of potassium citrate controlled-release tablet and preparation method thereof SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) 2016-01-06 CN disclosed
CN-103284974-A Phencynonate hydrochloride double-layer osmotic pump controlled release tablet and preparation method thereof WUHAN GENERAL HOSPITAL OF GUANGZHOU MILITARY 2013-09-11 CN disclosed
CN-102552205-A Potassium citrate controlled-release tablet preparation and preparation method thereof SHANGHAI INST MATERIA MEDICA 2012-07-11 CN disclosed
US-5770575-A Nipecotic acid derivatives as antithrombotic compounds ORTHO PHARMACEUTICAL CORPORATION (US) 1998-06-23 US disclosed
WO-1998013377-A1 CYTOTOXIC PEPTIDES BIOMOLECULAR RESEARCH INSTITUTE LTD. (AU) 1998-04-02 WO disclosed
EP-0746545-A1 NIPECOTIC ACID DERIVATIVES AS ANTITHROMBIC COMPOUNDS ORTHO PHARMACEUTICAL CORPORATION (US) 1996-12-11 EP disclosed
CN-1128022-A Nipecotic acid derivatives as antithrombic compounds ORTHO PHARMA CORP (US) 1996-07-31 CN disclosed
EP-0518484-A2 1,4-Benzodiazepines condesed with 5- and 6-membered heterocyclic rings to treat anxiety, pain, pupil constriction, withdrawal-syndrome or oncologic disorders MERCK & CO. INC. (US) 1992-12-16 EP disclosed
WO-1992003415-A1 PROTEIN KINASE C MODULATORS NOVA PHARMACEUTICAL CORPORATION (US) 1992-03-05 WO disclosed
US-4847248-A 1,4-Benzodiazepines with 5- and 6-membered heterocyclic rings and their use as cholecystokinins and gastrin antagonists MERCK & CO., INC. (US) 1989-07-11 US disclosed
EP-0272865-A1 1,4-Benzodiazepines with 5-and 6-membered heterocyclic rings MERCK & CO. INC. (US) 1988-06-29 EP disclosed
US-4735941-A 1,4-benzodiazepines with 5- and 6-membered heterocyclic rings, useful as gastrointestinal and CNS agents MERCK & CO., INC. (US) 1988-04-05 US disclosed